No Data
No Data
Brother Enterprises Holding (002562.SZ): The iodine contrast agent preparation products of the company are still in the research and development stage.
Brother Enterprises Holding (002562.SZ) stated on the investor interaction platform on July 19th that the company's iodine contrast agent preparation products are still in the research and development stage.
Brother Enterprises Holding (002562.SZ): its medical and food products mainly include vitamins, flavorings, pharmaceuticals, and other related products.
Brother Enterprises Holding (002562.SZ) stated on their investor interaction platform on July 15th that the company's main medical and food products include vitamins, flavors and fragrances, and pharmaceuticals. The main specialty chemicals include chromium salts, leather chemicals, and related products.
Brother Enterprises Holding: Brother Enterprises Holding's performance forecast for the first half of 2024.
Brother Enterprises Holding (002562.SZ) mainly focuses on research and development of products in the areas of neurology, metabolism, immunology, and respiration for formulation.
On July 2nd, Gelunhui reported that investors asked Brother Enterprises Holding (002562.SZ) on the investor interactive platform whether the company has rare disease drugs or is developing such drugs. The company replied that their formulations mainly focus on product research and development in the fields of nervous system, metabolism, immune system, and respiratory system. Currently there are no rare disease drugs.
Even After Rising 19% This Past Week, Brother Enterprises HoldingLtd (SZSE:002562) Shareholders Are Still Down 29% Over the Past Five Years
It's nice to see the Brother Enterprises Holding Co.,Ltd. (SZSE:002562) share price up 19% in a week. But over the last half decade, the stock has not performed well. You would have done a lot bet
Brother Enterprises Holding (002562.SZ): Some of the iodine contrast agent active pharmaceutical ingredients have been marketed and sold in India, Russia, Ukraine and other markets.
Brother enterprises holding (002562.SZ) stated on the investor interaction platform on June 20th that some of the company's raw materials for iodinated contrast agents have been marketed and sold in India, Russia, Ukraine and other markets, and the company is actively promoting the sales of raw materials for iodinated contrast agents in the global market.
No Data